Peanut-shaped gold nanoparticles with shells of ceragenin csa-131 display the ability to inhibit ovarian cancer growth in vitro and in a tumor xenograft model

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Peanut-shaped gold nanoparticles with shells of ceragenin csa-131 display the ability to inhibit ovarian cancer growth in vitro and in a tumor xenograft model. / Piktel, Ewelina; Oscilowska, Ilona; Suprewicz, Łukasz; Depciuch, Joanna; Marcińczyk, Natalia; Chabielska, Ewa; Wolak, Przemysław; Głuszek, Katarzyna; Klimek, Justyna; Zieliński, Piotr M.; Marzec, Michał T.; Savage, Paul B.; Parlińska-Wojtan, Magdalena; Bucki, Robert.

I: Cancers, Bind 13, Nr. 21, 5424, 2021, s. 1-26.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Piktel, E, Oscilowska, I, Suprewicz, Ł, Depciuch, J, Marcińczyk, N, Chabielska, E, Wolak, P, Głuszek, K, Klimek, J, Zieliński, PM, Marzec, MT, Savage, PB, Parlińska-Wojtan, M & Bucki, R 2021, 'Peanut-shaped gold nanoparticles with shells of ceragenin csa-131 display the ability to inhibit ovarian cancer growth in vitro and in a tumor xenograft model', Cancers, bind 13, nr. 21, 5424, s. 1-26. https://doi.org/10.3390/cancers13215424

APA

Piktel, E., Oscilowska, I., Suprewicz, Ł., Depciuch, J., Marcińczyk, N., Chabielska, E., Wolak, P., Głuszek, K., Klimek, J., Zieliński, P. M., Marzec, M. T., Savage, P. B., Parlińska-Wojtan, M., & Bucki, R. (2021). Peanut-shaped gold nanoparticles with shells of ceragenin csa-131 display the ability to inhibit ovarian cancer growth in vitro and in a tumor xenograft model. Cancers, 13(21), 1-26. [5424]. https://doi.org/10.3390/cancers13215424

Vancouver

Piktel E, Oscilowska I, Suprewicz Ł, Depciuch J, Marcińczyk N, Chabielska E o.a. Peanut-shaped gold nanoparticles with shells of ceragenin csa-131 display the ability to inhibit ovarian cancer growth in vitro and in a tumor xenograft model. Cancers. 2021;13(21):1-26. 5424. https://doi.org/10.3390/cancers13215424

Author

Piktel, Ewelina ; Oscilowska, Ilona ; Suprewicz, Łukasz ; Depciuch, Joanna ; Marcińczyk, Natalia ; Chabielska, Ewa ; Wolak, Przemysław ; Głuszek, Katarzyna ; Klimek, Justyna ; Zieliński, Piotr M. ; Marzec, Michał T. ; Savage, Paul B. ; Parlińska-Wojtan, Magdalena ; Bucki, Robert. / Peanut-shaped gold nanoparticles with shells of ceragenin csa-131 display the ability to inhibit ovarian cancer growth in vitro and in a tumor xenograft model. I: Cancers. 2021 ; Bind 13, Nr. 21. s. 1-26.

Bibtex

@article{4bb32bd619034d91ab3f40d1bd821e5a,
title = "Peanut-shaped gold nanoparticles with shells of ceragenin csa-131 display the ability to inhibit ovarian cancer growth in vitro and in a tumor xenograft model",
abstract = "Gold nanoparticles-assisted delivery of antineoplastics into cancerous cells is presented as an effective approach for overcoming the limitations of systemic chemotherapy. Although ceragenins show great potential as anti-cancer agents, in some tumors, effective inhibition of cancer cells proliferation requires application of ceragenins at doses within their hemolytic range. For the purpose of toxicity/efficiency ratio control, peanut-shaped gold nanoparticles (AuP NPs) were functionalized with a shell of ceragenin CSA-131 and the cytotoxicity of AuP@CSA-131 against ovarian cancer SKOV-3 cells and were then analyzed. In vivo efficiency of intravenously and intratumorally administered CSA-131 and AuP@CSA-131 was examined using a xenograft ovarian cancer model. Serum parameters were estimated using ELISA methods. Comparative analysis revealed that AuP@CSA-131 exerted stronger anti-cancer effects than free ceragenin, which was determined by enhanced ability to induce caspase-dependent apoptosis and autophagy processes via reactive oxygen species (ROS)-mediated pathways. In an animal study, AuP@CSA-131 was characterized by delayed clearance and prolonged blood circulation when compared with free ceragenin, as well as enhanced anti-tumor efficiency, particularly when applied intratumorally. Administration of CSA-131 and AuP@CSA-131 prevented the inflammatory response associated with cancer development. These results present the possibility of employing non-spherical gold nanoparticles as an effective nanoplatform for the delivery of antineoplastics for the treatment of ovarian malignancy.",
keywords = "Ceragenins, Drug delivery, Gold nanopeanuts, Nanotechnology, Non-spherical gold nanoparticles, Ovarian cancer",
author = "Ewelina Piktel and Ilona Oscilowska and {\L}ukasz Suprewicz and Joanna Depciuch and Natalia Marci{\'n}czyk and Ewa Chabielska and Przemys{\l}aw Wolak and Katarzyna G{\l}uszek and Justyna Klimek and Zieli{\'n}ski, {Piotr M.} and Marzec, {Micha{\l} T.} and Savage, {Paul B.} and Magdalena Parli{\'n}ska-Wojtan and Robert Bucki",
note = "Publisher Copyright: {\textcopyright} 2021 by the authors. Licensee MDPI, Basel, Switzerland.",
year = "2021",
doi = "10.3390/cancers13215424",
language = "English",
volume = "13",
pages = "1--26",
journal = "Cancers",
issn = "2072-6694",
publisher = "M D P I AG",
number = "21",

}

RIS

TY - JOUR

T1 - Peanut-shaped gold nanoparticles with shells of ceragenin csa-131 display the ability to inhibit ovarian cancer growth in vitro and in a tumor xenograft model

AU - Piktel, Ewelina

AU - Oscilowska, Ilona

AU - Suprewicz, Łukasz

AU - Depciuch, Joanna

AU - Marcińczyk, Natalia

AU - Chabielska, Ewa

AU - Wolak, Przemysław

AU - Głuszek, Katarzyna

AU - Klimek, Justyna

AU - Zieliński, Piotr M.

AU - Marzec, Michał T.

AU - Savage, Paul B.

AU - Parlińska-Wojtan, Magdalena

AU - Bucki, Robert

N1 - Publisher Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland.

PY - 2021

Y1 - 2021

N2 - Gold nanoparticles-assisted delivery of antineoplastics into cancerous cells is presented as an effective approach for overcoming the limitations of systemic chemotherapy. Although ceragenins show great potential as anti-cancer agents, in some tumors, effective inhibition of cancer cells proliferation requires application of ceragenins at doses within their hemolytic range. For the purpose of toxicity/efficiency ratio control, peanut-shaped gold nanoparticles (AuP NPs) were functionalized with a shell of ceragenin CSA-131 and the cytotoxicity of AuP@CSA-131 against ovarian cancer SKOV-3 cells and were then analyzed. In vivo efficiency of intravenously and intratumorally administered CSA-131 and AuP@CSA-131 was examined using a xenograft ovarian cancer model. Serum parameters were estimated using ELISA methods. Comparative analysis revealed that AuP@CSA-131 exerted stronger anti-cancer effects than free ceragenin, which was determined by enhanced ability to induce caspase-dependent apoptosis and autophagy processes via reactive oxygen species (ROS)-mediated pathways. In an animal study, AuP@CSA-131 was characterized by delayed clearance and prolonged blood circulation when compared with free ceragenin, as well as enhanced anti-tumor efficiency, particularly when applied intratumorally. Administration of CSA-131 and AuP@CSA-131 prevented the inflammatory response associated with cancer development. These results present the possibility of employing non-spherical gold nanoparticles as an effective nanoplatform for the delivery of antineoplastics for the treatment of ovarian malignancy.

AB - Gold nanoparticles-assisted delivery of antineoplastics into cancerous cells is presented as an effective approach for overcoming the limitations of systemic chemotherapy. Although ceragenins show great potential as anti-cancer agents, in some tumors, effective inhibition of cancer cells proliferation requires application of ceragenins at doses within their hemolytic range. For the purpose of toxicity/efficiency ratio control, peanut-shaped gold nanoparticles (AuP NPs) were functionalized with a shell of ceragenin CSA-131 and the cytotoxicity of AuP@CSA-131 against ovarian cancer SKOV-3 cells and were then analyzed. In vivo efficiency of intravenously and intratumorally administered CSA-131 and AuP@CSA-131 was examined using a xenograft ovarian cancer model. Serum parameters were estimated using ELISA methods. Comparative analysis revealed that AuP@CSA-131 exerted stronger anti-cancer effects than free ceragenin, which was determined by enhanced ability to induce caspase-dependent apoptosis and autophagy processes via reactive oxygen species (ROS)-mediated pathways. In an animal study, AuP@CSA-131 was characterized by delayed clearance and prolonged blood circulation when compared with free ceragenin, as well as enhanced anti-tumor efficiency, particularly when applied intratumorally. Administration of CSA-131 and AuP@CSA-131 prevented the inflammatory response associated with cancer development. These results present the possibility of employing non-spherical gold nanoparticles as an effective nanoplatform for the delivery of antineoplastics for the treatment of ovarian malignancy.

KW - Ceragenins

KW - Drug delivery

KW - Gold nanopeanuts

KW - Nanotechnology

KW - Non-spherical gold nanoparticles

KW - Ovarian cancer

UR - http://www.scopus.com/inward/record.url?scp=85118173032&partnerID=8YFLogxK

U2 - 10.3390/cancers13215424

DO - 10.3390/cancers13215424

M3 - Journal article

C2 - 34771587

AN - SCOPUS:85118173032

VL - 13

SP - 1

EP - 26

JO - Cancers

JF - Cancers

SN - 2072-6694

IS - 21

M1 - 5424

ER -

ID: 284639988